Grimes & Company, Inc. Adma Biologics, Inc. Put Options Transaction History
Grimes & Company, Inc.
- $3.66 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
295Shares Held
180MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$368 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$286 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$260 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$176 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$159 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.87B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...